(Joplin, MO) – NextGen Diagnostic Services, will now be offering NOWDiagnostics’ ADEXUSDx® COVID-19 antibody test, a rapid-results self-contained fingerstick test at our Joplin, Missouri NextGen Diagnostic Services testing sites.
The ADEXUSDx® test offers a fast and easy way to check for COVID-19 antibodies. The ADEXUSDx® COVID19 antibody test detects antibodies to a portion of the spike protein S1 of the SARS-CoV-2 virus. These antibodies are the most protective and are induced by vaccination, offering both vaccinated individuals an accurate way to test for antibodies even if they have not had a previous COVID-19 infection.
The test detects results in only 15 minutes and results will be reported via the Missouri Department of
Health. NOWDiagnostics’ advanced technology allows for easy use, and the self-contained fingerstick
provides a safe and virtually painless way to gather a sample.
In May 2021, NOWDiagnostics announced receipt of Emergency Use Authorization from the Food and
Drug Administration (FDA) for the ADEXUSDx® COVID-19 Test’s use in moderate complex settings and at the point of care. The Biomedical Advanced Research and Development Authority (BARDA) provided
funding and technical support to NOWDiagnostics for the development of the ADEXUSDx® COVID-19 Test. Trials for over-the-counter use are ongoing.
About NextGen Diagnostic Services:
NextGen Diagnostic Services is a certified laboratory that provides COVID-19 antibody testing and antigen testing to see if an individual has had a previous infection or if they have an active infection. NextGen Diagnostic Services was started in November of 2020 and has since travelled to many different areas of the state to offer COVID-19 testing by PCR through a collaboration with Dynamic DNA Laboratories of Springfield, Missouri.
About NOWDiagnostics, Inc.:
NOWDiagnostics, Inc., based in Springdale, Arkansas, is a leader in innovative diagnostics testing. Its ADEXUSDx® product line features a lab at the tip of your finger, using a single drop of blood to test for a variety of common conditions, illnesses, and diseases, with results in a matter of minutes. By eliminating the need to send tests to off-site laboratories, NOWDiagnostics products have the potential to decrease the waiting period to determine test results by days. For more information about NOWDiagnostics, visit nowdx.com.
Reference:
Claire Burghoff
NextGen Diagnostics
mcburghoff@cgagroup.com
Be the first to comment